Recombinant Human Adenosylhomocysteinease/AHCY Protein, CF

Catalog #: 6466-AH Datasheet / COA / SDS

Catalog #	Availability	Size / Price	Qty
6466-AH-010

R&D Systems Recombinant Proteins and Enzymes

1 Image

All Adenosylhomocysteinase/AHCY Proteins and Enzymes

Product Details

Reviews

Summary Product Datasheets Carrier Free Data Images Reconstitution Calculator Background Related Research Areas

Recombinant Human Adenosylhomocysteinease/AHCY Protein, CF Summary

Product Specifications

Purity

>95%, by SDS-PAGE visualized with Silver Staining and quantitative densitometry by Coomassie® Blue Staining.

Endotoxin Level

<1.0 EU per 1 μg of the protein by the LAL method.

Activity

Measured by the hydrolysis of S-adenosyl-L-homocysteine. The specific activity is >350 pmol/min/μg, as measured under the described conditions.

Source

E. coli-derived human Adenosylhomocysteinase/AHCY protein
Ser2-Tyr432, with an N-terminal Met and 6-His tag

Accession #

P23526

N-terminal Sequence
Analysis

Met

Predicted Molecular Mass

49 kDa

SDS-PAGE

43 kDa, reducing conditions

Product Datasheets

6466-AH

Product Datasheet

COA

SDS

Carrier Free

What does CF mean?

CF stands for Carrier Free (CF). We typically add Bovine Serum Albumin (BSA) as a carrier protein to our recombinant proteins. Adding a carrier protein enhances protein stability, increases shelf-life, and allows the recombinant protein to be stored at a more dilute concentration. The carrier free version does not contain BSA.

What formulation is right for me?

In general, we advise purchasing the recombinant protein with BSA for use in cell or tissue culture, or as an ELISA standard. In contrast, the carrier free protein is recommended for applications, in which the presence of BSA could interfere.

6466-AH

Formulation	Supplied as a 0.2 μm filtered solution in Tris, NaCl and Glycerol.
Shipping	The product is shipped with polar packs. Upon receipt, store it immediately at the temperature recommended below.
Stability & Storage:	Use a manual defrost freezer and avoid repeated freeze-thaw cycles. 6 months from date of receipt, -20 to -70 °C as supplied. 3 months, -20 to -70 °C under sterile conditions after opening.

Assay Procedure

Materials

Assay Buffer: 50 mM HEPES, 2 mM MgCl₂, 1 mM EDTA, pH 7.0
Recombinant Human Adenosylhomocysteinase/AHCY (rhAHCY) (Catalog # 6466-AH)
Glutathione, reduced (Amresco, Catalog # 399)
Adenosylhomocysteine (Sigma, Catalog # A9384), 10 mM stock in 10 mM HCl
Recombinant Human Adenosine Deaminase/ADA (rhADA) (Catalog # 7048-AD)
ThioGlo®3 Fluorescent Thiol Reagent (Covalent Associates, Inc., Catalog # T-003), 10 mM stock in DMSO
DMSO (Sigma, Catalog # 154938)
F16 Black Maxisorp Plate (Nunc, Catalog # 475515)
Fluorescent Plate Reader (Model: SpectraMax Gemini EM by Molecular Devices) or equivalent

Prepare a 10 mM stock of reduced glutathione in deionized water.
Prepare the standard curve by diluting the 10 mM reduced glutathione (10,000 pmol/µL) to 10 pmol/µL in Assay Buffer and performing six additional ½ serial dilutions.
Dilute rhAHCY to 0.667 μg/mL in Assay Buffer.
Dilute adenosylhomocysteine to 1 mM in Assay Buffer.
Dilute rhADA to 0.24 mg/mL in Assay Buffer.
Load the microplate as follows:
a. Reactions: 15 µL of 0.667 μg/mL rhAHCY, 15 µL of 0.24 mg/mL rhADA, and 20 µL of 1 mM adenosylhomocysteine
b. Substrate Blanks: 15 µL of Assay Buffer, 15 µL of 0.24 mg/mL rhADA, and 20 µL of 1 mM adenosylhomocysteine
c. Standard Curve: 50 µL per well
Cover microplate and incubate at 37 °C for 30 minutes.
Dilute ThioGlo® to 100 µM in DMSO.
After incubation, add 50 µL of 100 µM ThioGlo® to each well.
Incubate at room temperature for 5 minutes in the dark.
Read the plate in endpoint mode at excitation and emission wavelengths of 380 nm and 445 nm, respectively.
Calculate specific activity:

Specific Activity (pmol/min/µg) =	Free thiol produced*
	Incubation time (min) x amount of enzyme (µg)

*Derived from the reduced glutathione standard curve using linear fitting and adjusted for Substrate Blank.

Per Well:

rhAHCY: 0.010 µg
Adenosylhomocysteine: 200 µM
rhADA: 3.6 μg
ThioGlo®: 50 µM

Reconstitution Calculator

Background: Adenosylhomocysteinase/AHCY

Human S‑Adenosylhomocysteinase (AHCY) is a cytoplasmic tetramer with a tightly bound NAD co‑factor for each subunit (1, 2). It is the only known enzyme to catalyze the breakdown of S‑adenosylhomocysteine (AdoHcy) to homocysteine and adenosine. AdoHcy hydrolysis is a reversible reaction with an equilibrium favoring AdoHcy formation, but hydrolysis prevails under physiological conditions due to the rapid removal of adenosine and homocysteine. Thus, AHCY’s activity in mammals is directly related to homocysteine level, an independent risk factor for vascular disease (3). It also functions as a regulator of biological transmethylation by controlling the concentration of AdoHcy, a potent competitive inhibitor of all S-adenosyl-L-methionine methyltransferases (1). A mutation in the human AHCY results in AHCY deficiency with increase of plasma creatine kinase, methionine, S‑adenosylmethionine and AdoHcy, delay of myelination, myopathy and psychomotor retardation (4, 5).

References